Yao Wang Jiarui Chen Yueqiong Ni Yan Liu Xiang Gao Michael Andrew Tse Gianni Panagiotou Aimin Xu a State Key Laboratory of Pharmaceutical Biotechnology,The University of Hong Kong,Hong Kong,Chinab Department of Medicine,The University of Hong Kong,Hong Kong,Chinac Department of Obstetrics and Gynaecology,The Chinese University of Hong Kong,Hong Kong,Chinad Department of Microbiome Dynamics,Leibniz Institute for Natural Product Research and Infection Biology,Hans Knoll Institute,Jena,Germanye Centre for Sports and Exercise,The University of Hong Kong,Hong Kong,Chinaf Faculty of Biological Sciences,Friedrich Schiller University,Jena,Germanyg Jena University Hospital,Friedrich Schiller University,Jena,Germanyh Department of Pharmacology and Pharmacy,The University of Hong Kong,Hong Kong,China

Abstract:Background The importance of gut microbes in mediating the benefits of lifestyle intervention is increasingly recognized. However, compared to the bacterial microbiome, the role of intestinal fungi in exercise remains elusive. With our established randomized controlled trial of exercise intervention in Chinese males with prediabetes ( n = 39, ClinicalTrials.gov:NCT03240978), we investigated the dynamics of human gut mycobiome and further interrogated their associations with exercise-elicited outcomes using multi-omics approaches.

Exercise-changed gut mycobiome as a potential contributor to metabolic benefits in diabetes prevention: an integrative multi-omics study